MSH3 Gene Familial Adenomatous Polyposis Type 4 NGS Genetic DNA Test
Introduction
The MSH3 Gene Familial Adenomatous Polyposis Type 4 NGS Genetic DNA Test is a vital diagnostic tool that evaluates the presence of genetic mutations associated with familial adenomatous polyposis (FAP), a condition that significantly increases the risk of colorectal cancer. Understanding your genetic predisposition is crucial for early intervention and management of potential health risks.
What the Test Measures
This genetic test specifically analyzes the MSH3 gene, which plays a critical role in DNA repair. By identifying mutations within this gene, healthcare providers can assess the likelihood of developing FAP and related cancers.
Who Should Consider This Test
- Individuals with a family history of colorectal cancer or FAP.
- Patients exhibiting symptoms such as multiple polyps in the colon.
- Those who have undergone genetic counseling regarding their cancer risk.
Benefits of Taking the Test
- Early detection of genetic predisposition to cancer.
- Informed decision-making regarding surveillance and preventive measures.
- Guidance for family members who may also be at risk.
Understanding Your Results
Your test results will indicate whether mutations in the MSH3 gene are present. A positive result may suggest a higher risk for developing colorectal cancer, prompting further discussions with your healthcare provider about monitoring and preventive strategies. It is essential to consult with a genetic counselor to interpret your results accurately.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| MSH3 Gene Familial Adenomatous Polyposis Type 4 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book Your Test Today!
To gain insights into your genetic health and take proactive steps towards cancer prevention, book the MSH3 Gene Familial Adenomatous Polyposis Type 4 NGS Genetic DNA Test today. For more information or to schedule your appointment, call or WhatsApp us at +2348077798758.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-test Instructions: Clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected with the MSH3 gene.
Specialty and Department
This test is conducted under the guidance of oncologists in the genetics department using NGS technology, focusing on cancer-related genetic assessments.
